Actively Recruiting

Phase 4
Age: 20Years +
All Genders
NCT05347069

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

Led by Takeshi Morimoto · Updated on 2025-03-11

2890

Participants Needed

1

Research Sites

441 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the efficacy and safety aspirin in patients with chronic coronary syndromes without revascularization.

CONDITIONS

Official Title

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

Who Can Participate

Age: 20Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with chronic coronary syndromes with 50% diameter stenosis in one or more major coronary vessels or branches on coronary CT or angiography but not eligible for revascularization
  • Patients who can provide consent to participate
Not Eligible

You will not qualify if you...

  • Patients with history of acute coronary syndromes
  • Patients with history of percutaneous coronary intervention or coronary artery bypass graft
  • Patients with left main trunk stenosis of 50% or more
  • Patients for whom aspirin treatment is mandatory
  • Patients using antithrombotic therapy other than aspirin
  • Patients with atrial fibrillation
  • Patients with stroke within the last six months
  • Patients scheduled for major surgery requiring stopping aspirin
  • Patients with aspirin contraindications
  • Patients expected to live one year or less due to other illnesses
  • Women who can become pregnant or have a positive pregnancy test at enrollment
  • Patients deemed unsuitable to participate by their doctors

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Kyoto University Hospital

Kyoto, Japan

Actively Recruiting

Loading map...

Research Team

T

Takeshi Kimura, MD, PhD

CONTACT

E

Erika Yamamoto, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here